CME Group (CME) Stock Rating Upgraded by BidaskClub

BidaskClub upgraded shares of CME Group (NASDAQ:CME) from a sell rating to a hold rating in a report published on Thursday morning, BidAskClub reports.

A number of other research analysts have also recently commented on the stock. Bank of America restated a neutral rating and set a $191.00 price target (down previously from $200.00) on shares of CME Group in a research note on Friday, January 11th. They noted that the move was a valuation call. JPMorgan Chase & Co. started coverage on shares of CME Group in a research note on Friday, February 15th. They set an underweight rating and a $164.00 price target for the company. Jefferies Financial Group restated a buy rating and set a $204.00 price target on shares of CME Group in a research note on Wednesday, January 9th. Barclays cut their price target on shares of CME Group from $210.00 to $193.00 and set an overweight rating for the company in a research note on Tuesday, March 26th. Finally, Deutsche Bank cut their price target on shares of CME Group from $220.00 to $214.00 and set a buy rating for the company in a research note on Friday, March 15th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and six have issued a buy rating to the stock. The company has a consensus rating of Hold and a consensus target price of $192.00.

Shares of CME opened at $176.36 on Thursday. The stock has a market cap of $63.10 billion, a price-to-earnings ratio of 25.86, a price-to-earnings-growth ratio of 3.60 and a beta of 0.29. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.01 and a quick ratio of 1.01. CME Group has a 12 month low of $153.90 and a 12 month high of $197.08.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 14th. The financial services provider reported $1.77 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.02. The firm had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. CME Group had a net margin of 45.53% and a return on equity of 9.85%. The company’s revenue for the quarter was up 37.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.12 earnings per share. As a group, sell-side analysts anticipate that CME Group will post 6.81 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Monday, March 25th. Stockholders of record on Friday, March 8th were paid a $0.75 dividend. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.70%. This is a boost from CME Group’s previous quarterly dividend of $0.70. CME Group’s payout ratio is 43.99%.

In other CME Group news, Director Ronald A. Pankau sold 200 shares of CME Group stock in a transaction on Friday, March 1st. The shares were sold at an average price of $182.90, for a total transaction of $36,580.00. Following the completion of the sale, the director now owns 3,600 shares of the company’s stock, valued at approximately $658,440. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Martin J. Gepsman sold 3,000 shares of CME Group stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $167.91, for a total transaction of $503,730.00. Following the sale, the director now directly owns 39,799 shares of the company’s stock, valued at approximately $6,682,650.09. The disclosure for this sale can be found here. Insiders sold 28,489 shares of company stock valued at $4,948,996 in the last quarter. 1.20% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. IFM Investors Pty Ltd grew its holdings in shares of CME Group by 13.3% in the 1st quarter. IFM Investors Pty Ltd now owns 23,258 shares of the financial services provider’s stock valued at $3,828,000 after buying an additional 2,724 shares during the period. Appleton Partners Inc. MA grew its holdings in shares of CME Group by 6.3% in the 1st quarter. Appleton Partners Inc. MA now owns 15,099 shares of the financial services provider’s stock valued at $2,485,000 after buying an additional 892 shares during the period. Northpointe Capital LLC grew its holdings in shares of CME Group by 184.7% in the 1st quarter. Northpointe Capital LLC now owns 30,447 shares of the financial services provider’s stock valued at $5,011,000 after buying an additional 19,751 shares during the period. Argus Investors Counsel Inc. acquired a new position in shares of CME Group in the 1st quarter valued at $412,000. Finally, Steinberg Global Asset Management grew its holdings in shares of CME Group by 13.6% in the 1st quarter. Steinberg Global Asset Management now owns 5,247 shares of the financial services provider’s stock valued at $849,000 after buying an additional 629 shares during the period. 84.84% of the stock is owned by hedge funds and other institutional investors.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: How to Track your Portfolio in Google Finance

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.